Literature DB >> 24577622

Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia.

Michael J Berridge1.   

Abstract

Neurons have highly developed Ca(2+) signalling systems responsible for regulating many neural functions such as the generation of brain rhythms, information processing and the changes in synaptic plasticity that underpins learning and memory. The signalling mechanisms that regulate neuronal excitability are particularly important for processes such as sensory perception, cognition and consciousness. The Ca(2+) signalling pathway is a key component of the mechanisms responsible for regulating neuronal excitability, information processing and cognition. Alterations in gene transcription are particularly important as they result in subtle alterations in the neuronal signalling mechanisms that have been implicated in many neural diseases. In particular, dysregulation of the Ca(2+) signalling pathway has been implicated in the development of some of the major psychiatric diseases such as bipolar disorder (BPD) and schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577622     DOI: 10.1007/s00441-014-1806-z

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  55 in total

1.  The effect of hypocalcemia in early childhood on autism-related social and communication skills in patients with 22q11 deletion syndrome.

Authors:  Meghan Muldoon; Opal Y Ousley; Lisa J Kobrynski; Sheena Patel; Matthew E Oster; Samuel Fernandez-Carriba; Joseph F Cubells; Karlene Coleman; Bradley D Pearce
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-30       Impact factor: 5.270

Review 2.  Neuronal Ryanodine Receptors in Development and Aging.

Authors:  Nawaf Abu-Omar; Jogita Das; Vivian Szeto; Zhong-Ping Feng
Journal:  Mol Neurobiol       Date:  2017-01-19       Impact factor: 5.590

Review 3.  Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.

Authors:  A Devor; O A Andreassen; Y Wang; T Mäki-Marttunen; O B Smeland; C-C Fan; A J Schork; D Holland; W K Thompson; A Witoelar; C-H Chen; R S Desikan; L K McEvoy; S Djurovic; P Greengard; P Svenningsson; G T Einevoll; A M Dale
Journal:  Mol Psychiatry       Date:  2017-03-28       Impact factor: 15.992

Review 4.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

5.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

Review 6.  Sodium-Calcium Exchangers of the SLC8 Family in Oligodendrocytes: Functional Properties in Health and Disease.

Authors:  Samantha A Spencer; Edna Suárez-Pozos; Miguel Escalante; Yu Par Myo; Babette Fuss
Journal:  Neurochem Res       Date:  2020-01-11       Impact factor: 3.996

Review 7.  Targeting Mitochondrial Dysfunction for Bipolar Disorder.

Authors:  Maya Kuperberg; Sophie L A Greenebaum; Andrew A Nierenberg
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 8.  Intracellular Signaling Cascades in Bipolar Disorder.

Authors:  Gregory H Jones; Carola Rong; Aisha S Shariq; Abhinav Mishra; Rodrigo Machado-Vieira
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 9.  The genetics of bipolar disorder.

Authors:  Francis James A Gordovez; Francis J McMahon
Journal:  Mol Psychiatry       Date:  2020-01-06       Impact factor: 15.992

10.  The impact of hypocalcemia on full scale IQ in patients with 22q11.2 deletion syndrome.

Authors:  Katheryn Grand; Lorraine E Levitt Katz; T Blaine Crowley; Edward Moss; Megan Lessig; Vaneeta Bamba; Katherine Lord; Elaine H Zackai; Beverly S Emanuel; Kathleen Valverde; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-10       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.